Report cover image

United Kingdom Orthobiologics Market Outlook to 2033 - Orthobiologics, Cartilage Repair and Others

Publisher GlobalData
Published Oct 15, 2024
Length 58 Pages
SKU # GBDT19322028

Description

United Kingdom Orthobiologics Market Outlook to 2033 - Orthobiologics, Cartilage Repair and Others


Summary

GlobalData’s “United Kingdom Orthobiologics Market Outlook to 2033” is a comprehensive databook report, covering key market data on the United Kingdom Orthobiologics market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments - Orthobiologics, Cartilage Repair and Others

The United Kingdom Orthobiologics Market report provides key information and data on -
  • Annualized market revenues (USD), volume (units) and average prices (USD) data for each of the market segments. Data is provided from 2018 to 2033.
  • 2023 company share and distribution share data for Orthobiologics Market.
  • Global corporate-level profiles of key companies operating within the United Kingdom Orthobiologics Market. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is also available in the report.
Scope

United Kingdom Orthobiologics is segmented as follows -
  • Bone Grafts and Substitutes
  • Bone Growth Stimulators
  • Cartilage Repair
  • Soft Tissue Biologics
  • Viscosupplementation
Reasons to Buy

The United Kingdom Orthobiologics Market report helps you to develop -
  • Business strategies by identifying the key market segments poised for strong growth in the future.
  • Market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the market.
  • Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
  • Understand the key distribution channels and what’s the most preferred mode of product distribution - Identify, understand and capitalize.

Table of Contents

58 Pages
1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 What Is This Report About?
2.2 Orthobiologics Market Segmentation
2.3 Definitions of Markets Covered in the Report
3 Orthobiologics Market, United Kingdom
3.1 Orthobiologics Market, United Kingdom, Revenue ($m), 2018-2033
3.1.1 Bone Grafts and Substitutes Market, United Kingdom, Revenue ($m), by Segment, 2018-2033
3.1.2 Bone Growth Stimulators Market, United Kingdom, Revenue ($m), by Segment, 2018-2033
3.1.3 Cartilage Repair Market, United Kingdom, Revenue ($m), by Segment, 2018-2033
3.1.4 Soft Tissue Biologics Market, United Kingdom, Revenue ($m), by Segment, 2018-2033
3.1.5 Viscosupplementation Market, United Kingdom, Revenue ($m), by Segment, 2018-2033
3.2 Orthobiologics Market, United Kingdom, Volume (Units), 2018-2033
3.2.1 Bone Grafts and Substitutes Market, United Kingdom, Volume (Units), by Segment, 2018-2033
3.2.2 Bone Growth Stimulators Market, United Kingdom, Volume (Units), by Segment, 2018-2033
3.2.3 Cartilage Repair Market, United Kingdom, Volume (Units), by Segment, 2018-2033
3.2.4 Soft Tissue Biologics Market, United Kingdom, Volume (Units), by Segment, 2018-2033
3.2.5 Viscosupplementation Market, United Kingdom, Volume (Units), by Segment, 2018-2033
3.3 Orthobiologics Market, United Kingdom, Average Price ($) , 2018-2033
3.4 Orthobiologics Market, United Kingdom, Distribution Share by Revenue ($m), 2023
3.5 Orthobiologics Market, United Kingdom, Company Share by Revenue ($m), 2023
4 Overview of Key Companies in United Kingdom, Orthobiologics Market
4.1 Medtronic Plc
4.1.1 Company Overview
4.2 Sanofi
4.2.1 Company Overview
4.3 Stryker Corp
4.3.1 Company Overview
4.4 ZimVie Inc
4.4.1 Company Overview
4.5 Orthofix Holdings Inc
4.5.1 Company Overview
4.6 Bioventus Inc
4.6.1 Company Overview
4.7 Fidia farmaceutici SpA
4.7.1 Company Overview
4.8 Globus Medical Inc
4.8.1 Company Overview
4.9 Zimmer Biomet Holdings Inc
4.9.1 Company Overview
5 Orthobiologics Market Pipeline Products
6 Financial Deals Landscape
6.1 Acquisition
6.1.1 Lifco to Acquire Ortho-Care UK
6.2 Debt Offerings
6.2.1 Smith & Nephew (Smith+Nephew) Raises USD350 Million in Public Offering of 5.15% Senior Notes Due 2027
6.2.2 Smith & Nephew (Smith+Nephew) Raises USD650 Million in Public Offering of 5.4% Senior Notes Due 2034
7 Recent Developments
7.1 Corporate Communications
7.1.1 Aug 21, 2024: AGFA HealthCare Announces the UK AGFA HealthCare User Group
7.1.2 Feb 12, 2024: Smith+Nephew to Attend AAOS 2024 Annual Meeting
7.2 Financial Announcements
7.2.1 Sep 10, 2024: Tissue Regenix Group Announces Interim Results for Six Months Ended June 30, 2024
7.3 Strategy And Business Planning
7.3.1 Apr 25, 2024: Starton Therapeutics Announces Enrollment Completion for STAR-LLD Phase 1B Clinical Trial in Multiple Myeloma
8 Appendix
8.1 Research Methodology
8.1.1 Coverage
8.1.2 Secondary Research
8.1.3 Primary Research
8.1.4 Market Modeling and Forecasting
8.1.5 Company Share Analysis
8.1.6 Distribution Share Analysis
8.1.7 Benchmarking
8.2 GlobalData Consulting
8.3 Contact Us
8.4 Disclaimer
List of Tables
Table 1: Orthobiologics Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033
Table 2: Bone Grafts and Substitutes Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033
Table 3: Bone Growth Stimulators Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033
Table 4: Cartilage Repair Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033
Table 5: Soft Tissue Biologics Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033
Table 6: Viscosupplementation Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033
Table 7: Orthobiologics Market, United Kingdom, Volume (Units), 2018-2033
Table 8: Bone Grafts and Substitutes Market, United Kingdom, Volume (Units), 2018-2033
Table 9: Bone Growth Stimulators Market, United Kingdom, Volume (Units), 2018-2033
Table 10: Cartilage Repair Market, United Kingdom, Volume (Units), 2018-2033
Table 11: Soft Tissue Biologics Market, United Kingdom, Volume (Units), 2018-2033
Table 12: Viscosupplementation Market, United Kingdom, Volume (Units), 2018-2033
Table 13: Orthobiologics Market, United Kingdom, Average Price ($), 2018-2033
Table 14: Orthobiologics Market, United Kingdom, Distribution Share by Revenue ($m), USD Constant, 2023
Table 15: Orthobiologics Market, United Kingdom, Company Share by Revenue ($m), USD Constant, 2023
Table 16: Orthobiologics Market Pipeline Products
Table 17: Lifco to Acquire Ortho-Care UK
Table 18: Smith & Nephew (Smith+Nephew) Raises USD350 Million in Public Offering of 5.15% Senior Notes Due 2027
Table 19: Smith & Nephew (Smith+Nephew) Raises USD650 Million in Public Offering of 5.4% Senior Notes Due 2034
Table 20: Total Number of Primary Research Participants, Orthopedic Devices Market, by Country
List of Figures
Figure 1: Orthobiologics Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033
Figure 2: Bone Grafts and Substitutes Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033
Figure 3: Bone Growth Stimulators Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033
Figure 4: Cartilage Repair Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033
Figure 5: Soft Tissue Biologics Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033
Figure 6: Viscosupplementation Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033
Figure 7: Orthobiologics Market, United Kingdom, Volume (Units), 2018-2033
Figure 8: Bone Grafts and Substitutes Market, United Kingdom, Volume (Units), 2018-2033
Figure 9: Bone Growth Stimulators Market, United Kingdom, Volume (Units), 2018-2033
Figure 10: Cartilage Repair Market, United Kingdom, Volume (Units), 2018-2033
Figure 11: Soft Tissue Biologics Market, United Kingdom, Volume (Units), 2018-2033
Figure 12: Viscosupplementation Market, United Kingdom, Volume (Units), 2018-2033
Figure 13: Orthobiologics Market, United Kingdom, Company Share (%) 2023

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us